Related Experiment Video
Updated: Jul 19, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
FcgammaRII and multi-system autoimmune disease
Nicholas C van de Velde1, Patricia L Mottram, P Mark Hogarth
1Burnet Institute (Austin Campus), Austin Hospital, Studley Road, Heidelberg, Victoria, 3084, Australia, pm.hogarth@burnet.edu.au.
Springer Seminars in Immunopathology
|November 9, 2006
Summary
The Fc gamma receptor II (FcgammaRII) regulates adaptive immunity and its dysfunction contributes to autoimmune diseases like lupus and rheumatoid arthritis. Understanding FcgammaRII is key to immune complex-mediated autoimmunity.
Area of Science:
- Immunology
- Molecular Biology
- Autoimmunity
Background:
- Fc receptors (FcR) bridge humoral and cellular immunity, mediating diverse physiological responses.
- Fc receptors for IgG (FcgammaR), especially FcgammaRII, are critical regulators of adaptive immunity.
- Dysfunctional FcgammaRII is implicated in autoimmune diseases like systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
Purpose of the Study:
- To review the structure and function of FcgammaRII.
- To discuss the role of FcgammaRII in immune complex-mediated autoimmunity.
- To explore the link between FcgammaRII polymorphisms and human diseases.
Main Methods:
- Review of existing literature on FcgammaRII structure/function.
- Analysis of associations between FcR polymorphisms and human disease.
- Examination of data from knockout and transgenic mouse models.
Main Results:
- FcgammaRII interacts with immune complexes, initiating or inhibiting inflammation.
- FcgammaRII receptors, alongside genotype and environmental factors, dictate immune responses.
- Studies reveal the complex role of FcgammaRII in regulating inflammatory processes.
Conclusions:
- FcgammaRII plays a pivotal role in adaptive immunity and autoimmune disease pathogenesis.
- Understanding FcgammaRII function is crucial for developing therapies for immune-mediated inflammatory conditions.
- Further research into FcgammaRII polymorphisms and their disease associations is warranted.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...